© 2021 Verizon Media. Why Legend Biotech Stock Is Sinking Today A customs investigation is sending this Chinese biotech stock lower today. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. Shares of the company owned by company insiders and major shareholders are now eligible to be traded as a result of the expiration of the lock-up period. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Shares in Legend Biotech are currently priced at $28.16. After a Post-Earnings Drop, is it Time to Ride PetMed Express? MarketBeat's community ratings are surveys of what our community members think about Legend Biotech and other stocks. The average Legend Biotech stock price for the last 52 weeks is 32.07. Want to see which stocks are moving? LEGN's rank also includes a long-term technical score of 0. Minimum 15 minutes delayed. To see all exchange delays and terms of use please see disclaimer. Get today's Legend Biotech Corp stock price and latest LEGN news as well as Legend Bio real-time stock quotes, technical analysis, full financials and more. Further, it has various product candidates in early preclinical and clinical development for the treatment of solid tumors, as well as infectious diseases. Legend Biotech intends to raise $350 million in an IPO of its ADSs representing ordinary shares, per an amended registration statement.The company … MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. On average, they expect Legend Biotech's stock price to reach $50.67 in the next year. Currency in USD, Trade prices are not sourced from all markets, The Big Electric Vehicle Story Everyone's Missing. Do Not Sell My Information. Legend Biotech Corp stock is up 4.22% since Friday, June 5, 2020 when Legend Biotech Corp began trading.InvestorsObserver’s proprietary ranking system, gives LEGN stock a score of 0 out of a possible 100.. That rank is chiefly influenced by a short-term technical score of 0. According to analysts' consensus price target of $50.67, Legend Biotech has a forecasted upside of 85.3% from its current price of $27.35. In addition, the company is developing an allogeneic CAR-T product candidate targeting CD20 for the treatment of NHL, which is currently in an investigator-initiated Phase 1 clinical trial in China. Legend Biotech Corporation (NASDAQ: LEGN) ("Legend Biotech"), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, announced today the initiation of a rolling submission of a Biologics License Application (BLA) to the Food and Drug Administration (FDA) for ciltacabtagene autoleucel (cilta-cel), an investigational B-cell maturation antigen (BCMA)-directed chimeric antigen receptor (CAR) T cell therapy, for the treatment of adults with relapsed and/or refractory multiple myeloma. You may vote once every thirty days. Its lead product candidate, LCAR-B38M/JNJ-4528, is an autologous CAR-T cell therapy that targets the B-cell maturation antigen. Legend Biotech has received 58.33% “underperform” votes from our community. Company profile page for Legend Biotech Corp including stock price, company news, press releases, executives, board members, and contact information Legend Biotech Corp is a clinical-stage biopharmaceutical company. The consensus among Wall Street equities research analysts is that investors should "buy" Legend Biotech stock. Legend Biotech to Participate in the 39th Annual J.P. Morgan Healthcare Conference. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Legend Biotech trades on the NASDAQ under the ticker symbol "LEGN.". You can opt out at any time. Fundamental company data provided by Morningstar and Zacks Investment Research. View Legend Biotech's earnings history. (Add your “underperform” vote.). Vote “Underperform” if you believe LEGN will underperform the S&P 500 over the long term. George Budwell (TMFGBudwell) Sep 21, … View all of LEGN's competitors. Dive deeper with interactive charts and top stories of Legend Biotech Corporation. Legend Biotech employs 800 workers across the globe. The 12-month stock price forecast is 50.67, which is an increase of 56.39% from the latest price. Legend’s IPO is the biggest for a biotech company this year since cancer drug developer Revolution Medicines (NASDAQ: RVMD) raised $238 million in its stock market debut. Shares of LEGN can be purchased through any online brokerage account. The company’s stock has been forecasted to trade at an average price of $50.67 over the course of the next 52 weeks, with a low of $47 and a high of $55. LEGN is up $1.32 from the previous closing price of $27.50 on volume of 84,453 shares. Only 18.92% of the stock of Legend Biotech is held by institutions. The company is conducting multiple clinical trials to evaluate LCAR-B38M/JNJ-4528 as an earlier line of therapy for multiple myeloma (MM), as well as a comparison of the treatment with standard triplet therapy in Revlimid-refractory MM. Data Provided by Refinitiv. Please log in to your account or sign up in order to add this asset to your watchlist. Why Legend Biotech Stock Is Sinking Today George Budwell 9/21/2020. Learn more. Legend Biotech, a clinical stage CAR-T immuno-oncology biotech being spun out of GenScript, raised $424 million by offering 18.4 million ADSs at $23, above the range of $18 to $20. Morgan Stanley, J.P. Morgan Securities and Jefferies acted as the underwriters for the IPO. Legend Biotech Corp is primarely in the business of pharmaceutical preparations. See what's happening in the market right now with MarketBeat's real-time news feed. Legend Biotech's mailing address is 2101 COTTONTAIL LANE, SOMERSET NJ, 08873. Stock Chart. View the latest Legend Biotech Corp. ADR (LEGN) stock price, news, historical charts, analyst ratings and financial information from WSJ. Legend Biotech Announcement Regarding ASH 2020 Data Presentation for Cilta-cel. If you had invested in Legend Biotech Corp stock at $37.00, your return over the last 0 years would have been -15%. The company can be reached via phone at 732-317-5050 or via email at [email protected]. View the latest LEGN stock quote and chart on MSN Money. Stock analysis for Legend Biotech Corp (LEGN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Asia Today: Australia OKs Pfizer vaccine, to begin in Feb. Tufin Software (NYSE: TUFN) Stock is Ready for Multiple Expansion, eBay (NASDAQ: EBAY) Earnings Report: Here’s What to Watch For, 3 Clean Energy Stocks that Could Get Boosted by Biden, Why These 3 ETFs Should be in Your 2021 Portfolio, Buy Kinder Morgan, Inc While It Still Yields 6.75%. Legend Biotech does not currently pay a dividend. Junshi Biosciences, Legend Biotech and Zai Lab Are 3 Top Chinese Biotechs Nov. 19, 2020 at 2:19 p.m. (Add your “outperform” vote. Latest Share Price and Events Stable Share Price : LEGN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week. Looking for new stock ideas? Vote “Outperform” if you believe LEGN will outperform the S&P 500 over the long term. Legend Biotech is a multinational biopharmaceutical company focused on discovering and developing cutting-edge cell-based therapies with the ultimate goal of … 3 Wall Street analysts have issued 1-year price targets for Legend Biotech's stock. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Get short term trading ideas from the MarketBeat Idea Engine. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 It also has a broad portfolio of earlier-stage autologous product candidates targeting various cancers, including non-hodgkins lymphoma (NHL), acute myeloid leukemia, and T cell lymphoma. Legend Biotech Corporation American Depositary Shares (LEGN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Ying Huang, PhD, Chief Executive Officer and Chief Financial Officer of Legend Biotech, will present company updates on Wednesday, January 13, 2021 at 4:30 pm ET. United States Legend Biotech USA Inc. Piscataway location 10 Knightsbridge Road Piscataway, NJ 08854, USA 1.732.317.5050 Somerset location 2101 Cottontail Lane Somerset, NJ 08873, USA info@legendbiotech.com. The company reported ($0.50) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.31) by $0.19. Sign-up to receive the latest news and ratings for LEGN and its competitors with MarketBeat's FREE daily newsletter. Legend Biotech has filed for an IPO. The company was founded in 2014 and is based in Somerset, New Jersey. Learn about financial terms, types of investments, trading strategies and more. Many soldiers, no protesters: Washington is quiet Sunday, but experts say capital should remain vigilant. Legend Biotech Corp (LEGN) stock is higher by 4.78% while the S&P 500 is lower by -1.16% as of 10:35 AM on Tuesday, Sep 22. Legend Biotech has received 5 “outperform” votes. Legend Biotech does not have a long track record of dividend growth. Legend Biotech's lock-up period expired on Wednesday, December 2nd. Wall Street analysts have given Legend Biotech a "Buy" rating, but there may be better short-term opportunities in the market. A high-level overview of Legend Biotech Corporation (LEGN) stock. Price Target Quick Take. 27.35 0.00 (0.00%)Before hours: 5:52AM EST, Subscribe to Premium to view Fair Value for LEGN. View analysts' price targets for Legend Biotech or view Wall Street analyst' top-rated stocks. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Legend Biotech is a clinical stage biopharmaceutical company engaged in the discovery and development of novel cell therapies in hematology/oncology, infectious diseases and auto-immune disorders. While investors are obsessed with Tesla's surge, legendary investor Whitney Tilson says an even bigger EV story will provide the highest gains. © American Consumer News, LLC dba MarketBeat® 2010-2021. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Legend Biotech Corp stock was originally listed at a price of $37.00 in Jun 5, 2020. For financial reporting, their fiscal year ends on December 31st. The total size of the offering was $423,775,000 based on an initial share price of $23.00. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. The Chinese CAR-T player plans to list its stock in the U.S. to fund the advance of a pipeline spearheaded by Johnson & … According to 3 analysts, the average rating for Legend Biotech stock is "Buy." Find the latest Legend Biotech Corporation (LEGN) stock quote, history, news and other vital information to help you with your stock trading and investing. View which stocks are hot on social media with MarketBeat's trending stocks report. The Legend Biotech 52-week low stock price is 24.64, which is 16.7% below the current share price. One share of LEGN stock can currently be purchased for approximately $27.35. View analyst ratings for Legend Biotech or view MarketBeat's top 5 stock picks. Legend Biotech Corporation (LEGN Quick Quote LEGN - Free Report) was a big mover last session, as the company saw its shares rise more than 6% … Legend Biotech had issued 18,425,000 shares in its public offering on June 5th. 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Legend Biotech in the last twelve months. Over the past year the S&P 500 is higher by 2.73% while LEGN is lower by -22.11%. CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 3D Printing Stocks Offering Another Dimension of Gains, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. The total size of the offering was $423,775,000 based on an initial share price of $23.00. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Analysts covering Legend Biotech currently have a consensus Earnings Per Share (EPS) forecast of -1.37 for the next financial year. Legend Biotech had issued 18,425,000 shares in its IPO on June 5th. Furthermore, Legend Biotech Corporation (LEGN)’s beta value is 0, and its average true range (ATR) is 1.65. Detailed financial statements for Legend Biotech stock (LEGN), including the income statement, balance sheet, and cash flow statement. Receive a free world-class investing education from MarketBeat. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. In the past three months, Legend Biotech insiders have not sold or bought any company stock. As of 2020 October 17, Saturday current price of LEGN stock is 28.835$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Legend Biotech Corp. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. of Investor Relations & Corp. Communications, Start Your Risk-Free Trial Subscription Here, Indonesia says it has seized Iranian and Panamanian tankers, The Latest: France faces 3rd lockdown if curfew not enough, Trapped for 2 weeks, 11 workers rescued from China gold mine, White House begins talks with lawmakers on COVID-19 relief, Asian shares rise on recovery hopes, markets eye earnings, Average US price of gas up 10 cents a gallon to $2.45. Legend Biotech Corporation, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel cell therapies for oncology and other indications. The Legend Biotech 52-week high stock price is 43.24, which is 46.2% above the current share price. Since the expiration of Legend Biotech's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company have been lifted. The company issued 18,400,000 shares at a price of $18.00-$20.00 per share. Legend Biotech and Noile-Immune Biotech Announce Collaborative Research and Licensing Agreement Apr 01, 2020 Legend Biotech Raises $150.5 Million in Series A Preferred Financing To Advance its Oncology Pipeline and Platform The all-time high Legend Biotech stock closing price was 42.56 on June 30, 2020. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. Legend Biotech had a negative net margin of 543.73% and a negative trailing twelve-month return on equity of 205.60%. Earnings for Legend Biotech are expected to grow in the coming year, from ($1.12) to ($0.63) per share. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell … There are currently 3 buy ratings for the stock. Legend Biotech has received a consensus rating of Buy. About the Legend Biotech Corp. stock forecast. Director of Strategic Marketing & Corp. Communications, Mang. ), Legend Biotech has received 7 “underperform” votes. The company earned $11.75 million during the quarter, compared to analysts' expectations of $12.80 million. Based on aggregate information from My MarketBeat watchlists, some companies that other Legend Biotech investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), CrowdStrike (CRWD), Lam Research (LRCX), ServiceNow (NOW), Peloton Interactive (PTON), QUALCOMM (QCOM), Applied Materials (AMAT), DocuSign (DOCU) and Etsy (ETSY). Identify stocks that meet your criteria using seven unique stock screeners. MarketBeat just released five new trading ideas, but Legend Biotech wasn't one of them. All rights reserved. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation. Legend Biotech’s stock opened at $37, giving the company a market valuation of $4.79 billion. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. This suggests a possible upside of 85.3% from the stock's current price. The official website for Legend Biotech is www.legendbiotech.com. How has Legend Biotech's share price performed over time and what events caused price changes? Learn everything you need to know about successful options trading with this three-part video course. Legend Biotech Corporation (NASDAQ: LEGN) ("Legend Biotech"), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, will participate virtually in the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021. Legend Biotech's management team includes the following people: Ph.D., Co-Founder & Chief Scientific Officer, Exec. Get daily stock ideas top-performing Wall Street analysts. Legend Biotech has a market capitalization of $3.53 billion and generates $64.39 million in revenue each year. Export data to Excel for your own analysis. All rights reserved. View our full suite of financial calendars and market data tables, all for free. The Legend Biotech Corporation stock price gained 1.04% on the last trading day (Tuesday, 1st Dec 2020), rising from $29.73 to $30.04. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Legend operates in the USA, mainland China and Ireland. Their forecasts range from $47.00 to $55.00. Legend Biotech Co. (NASDAQ:LEGN) announced its quarterly earnings data on Sunday, November, 15th. At that level they are trading at 0.26% discount to the analyst consensus target price of 0.00. ET on GuruFocus.com Legend Biotech (LEGN) in Focus: Stock Moves 6.2% Higher Legend Biotech Corp is registered with the U.S. Security and Exchange Commission and incorporated in the state of Cayman Islands. With Legend Biotech Corp stock trading at $31.45 per share, the total value of Legend Biotech Corp stock (market capitalization) is $4.07B. Legend Biotech has only been the subject of 1 research reports in the past 90 days. Learn more. Legend Biotech Corporation stock price up 1.04% on Tuesday (Updated on December 01, 2020) Buy candidate since 2020-11-20 Gain 3.94% PDF . © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. (LEGN) raised $350 million in an initial public offering on Friday, June 5th 2020. Some companies that are related to Legend Biotech include Teva Pharmaceutical Industries (TEVA), Grifols (GRFS), Dr. Reddy's Laboratories (RDY), Mirati Therapeutics (MRTX), Zai Lab (ZLAB), Bausch Health Companies (BHC), Jazz Pharmaceuticals (JAZZ), Ionis Pharmaceuticals (IONS), Ascendis Pharma A/S (ASND), Ultragenyx Pharmaceutical (RARE), BridgeBio Pharma (BBIO), Arrowhead Pharmaceuticals (ARWR), ACADIA Pharmaceuticals (ACAD), Sarepta Therapeutics (SRPT) and United Therapeutics (UTHR).

What Animal Is Felix Piggy, Muhammad Mirza Son, Capri, Italy Food, Ellioti Cichlid Temperament, Who Was Pharaoh When Abraham Went To Egypt, Dulux Paint Colours App, Apartments In Riverside, Wichita, Ks, Cvs Nebulizer Mask, Tanaman Daun Merah Kecil, Best Uni Sapporo, Lladro Figurines Value, Walter Scott Books,